RxDoctor Payments Data

Scott Soltys, MD

Radiation Oncology · Stanford, CANPI 1568500551

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $13,900 of the $18,782 with a category attached, or 74.0%. 6 manufacturers reported payments, led by Accuray Incorporated at 59.7% of the total. Reporting peaked in 2022 at $8,391 and has fallen 83.2% since, to $1,412 in 2025. Among radiation oncology clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$18,782in general payments, 2019–2025

Across 21 payments — averaging $894.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Accuray Incorporated$11K
  • Novocure Inc.$6K
  • Brainlab, Inc.$1K
  • Zap Surgical Systems, Inc.$300
  • Viewray Technologies Inc$180
  • Icotec Medical Inc.$112
$194,832in research payments, 2019–2025

Across 5 payments — averaging $38,966 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Novocure Inc.$195K

What the payments were for

  • Consulting fees$2,00011%
  • Speaking & faculty fees$13,90074%
  • Grants$3002%
  • Travel & lodging$1,7039%
  • Food & beverage$8805%

General payments by program year

21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Accuray Incorporated13$11,212
Novocure Inc.3$5,944
Brainlab, Inc.2$1,035
Zap Surgical Systems, Inc.1$300
Viewray Technologies Inc1$180
Icotec Medical Inc.1$112

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$18,782 in reported general payments places this provider in the 90th percentile of 627 radiation oncology providers in California.

See all radiation oncology providers in California

Medicare billing

Part B allowed, 2024
$134,498
Medicare patients
155
Services billed
1,327

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other radiation oncology in Stanford

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →